Abstract: 1063 DALCETRAPIB HAS NO CLINICALLY RELEVANT...

Atherosclerosis Supplements 2009 / 6 Vol. 10; Iss. 2

Abstract: 1063 DALCETRAPIB HAS NO CLINICALLY RELEVANT DRUG-DRUG INTERACTIONS WITH PRAVASTATIN OR ROSUVASTATIN

Derks, M, Abt, M, Phelan, M, Turnbull, L, Meneses-Lorente, G, Bech, N
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(09)70404-0
Date:
June, 2009
File:
PDF, 82 KB
english, 2009
Conversion to is in progress
Conversion to is failed